Bayforest Capital’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,781
Closed -$215K 874
2024
Q4
$215K Buy
+31,781
New +$215K 0.27% 123